BRIDGEWATER, N.J., Oct. 3, 2013 /PRNewswire/ — Savient Pharmaceuticals, Inc. (Nasdaq: SVNT)today announced that several abstracts related to KRYSTEXXA® (pegloticase) have been selected for presentation at the American College of Rheumatology (ACR) / Association of Rheumatology Health Professionals (ARHP) 2013 Annual Meeting. The 2013 ACR/ARHP annual meeting will be held October 26-30, 2013, in San Diego, CA.
Savient Announces Multiple Abstracts Related to KRYSTEXXA® to be Presented at the 2013 ACR/ARHP Annual Meeting
Categories: Life Sciences Industry Network
Daily updates about the region's most tech savvy companies